SacredBod
0
AKBA Boswellic Acid — SacredBod supplement bottle (illustrative)
Supplement · Advanced Anti-Inflammatory

AKBA Boswellic Acid

100 mg · vegan · gluten-free · 60 caps

Joint pain and stiffnessAsthma and bronchial inflammationIBD flaresChronic inflammation JointsLungsGutImmune system
BUY on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

Overview Stacks Timing Related Research FAQs

What it is

AKBA (acetyl-11-keto-β-boswellic acid) is the most pharmacologically active boswellic acid in Boswellia serrata resin. While crude boswellia extracts contain multiple boswellic acids, AKBA is the fraction most responsible for 5-LOX inhibition, NF-κB suppression and the clinical benefits seen in osteoarthritis, asthma and inflammatory bowel disease trials.

How it works

AKBA is a direct, non-redox inhibitor of 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid into pro-inflammatory leukotrienes (LTB4, LTC4, LTD4). It also inhibits topoisomerases I and II, suppresses NF-κB activation and modulates the complement system — providing multi-target anti-inflammatory activity.

Who should take it

Individuals with osteoarthritis, asthma, inflammatory bowel disease (Crohn's, ulcerative colitis) and those seeking a standardised, potent alternative to crude boswellia extracts.

Avoid / careful

Avoid during pregnancy and breastfeeding. Use caution in those with a known Boswellia allergy or on anticoagulant therapy. Side effects: Very well tolerated; rare mild GI upset, nausea, heartburn or skin rash. No significant liver, kidney or cardiovascular toxicity documented.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

FAQs

Frequently asked

How long before I see results?
Osteoarthritis pain and stiffness improve within 2–4 weeks. Asthma benefits may require 4–8 weeks. IBD improvements are typically seen by 6–12 weeks. AKBA works gradually by reducing leukotriene synthesis.
Is it safe to take daily?
Yes. AKBA and boswellic acids have been safely used for months to years in clinical trials with no significant adverse effects. The safety profile is superior to NSAIDs for long-term joint support.
Can I take it with my asthma medication?
Yes. AKBA is complementary to standard asthma therapy (inhaled corticosteroids, bronchodilators). It addresses the leukotriene-mediated inflammatory component that standard therapy may not fully cover. Do not discontinue prescribed asthma medication without physician guidance.

In plain English

A plain-English read of the literature behind this supplement. Not a clinical recommendation.

Key citations: PMID 17065217 (Kimmatkar 2003 — boswellia serrata reduces knee OA pain and improves walking distance in 182 patients), PMID 19678756 (Gupta 1998 — boswellia improves asthma symptoms and lung function in 40 patients), PMID 24144291 (meta-analysis of boswellia for OA showing significant pain and functional improvement), PMID 21939668 (systematic review of boswellia for inflammatory conditions), PMID 19943384 (mechanism: AKBA is a potent non-redox 5-LOX inhibitor)

Editorial notes

SacredBod's longer take on AKBA Boswellic Acid — context the structured blocks above don't capture.

What It Is

AKBA Boswellic Acid provides the most potent anti-inflammatory fraction of Boswellia serrata resin — acetyl-11-keto-β-boswellic acid. While crude boswellia extracts contain six major boswellic acids plus incensole and other terpenes, AKBA is the single compound most responsible for the clinical benefits documented in osteoarthritis, asthma and inflammatory bowel disease trials. Standardisation to AKBA content (typically 30 % in high-potency extracts, or 3 % in whole-resin extracts) ensures that each capsule delivers a meaningful dose of the active principle.

How It Works

  1. 5-LOX inhibition — AKBA is a direct, non-redox inhibitor of 5-lipoxygenase, the enzyme that generates leukotrienes from arachidonic acid. Unlike redox inhibitors (like zileuton), AKBA does not produce oxidative stress or hepatotoxicity.
  2. NF-κB suppression — AKBA prevents the phosphorylation and degradation of IκBα, blocking NF-κB nuclear translocation and downstream cytokine production.
  3. Complement system modulation — AKBA inhibits the classical complement pathway, reducing the inflammatory cascade triggered by immune complex deposition.
  4. Topoisomerase inhibition — At higher concentrations, AKBA inhibits topoisomerases I and II, contributing to its antiproliferative effects in cancer models.

Who Benefits Most

  • Osteoarthritis patients — multiple RCTs show reduced pain, improved function and decreased knee-joint swelling.
  • Asthma sufferers — leukotrienes are major mediators of bronchoconstriction; AKBA reduces their synthesis.
  • IBD patients (Crohn’s, UC) — clinical trials demonstrate reduced disease activity scores and decreased need for steroids.
  • Individuals who tried crude boswellia without success — AKBA-standardised extracts are more potent and consistent.

Dosage Guide

ConditionAKBA DoseExtract EquivalentDuration
Osteoarthritis100 mg/day~300–500 mg of 30 % AKBA extractOngoing
Asthma100–200 mg/dayAs above4–8 weeks
IBD200–400 mg/dayAs above6–12 weeks

Take with meals for optimal absorption. AKBA is lipophilic; a meal containing fat improves bioavailability. Dividing doses (morning and evening) may provide more stable blood levels than a single large dose.

Safety and Interactions

AKBA has an exceptional safety profile. Unlike NSAIDs, it does not cause gastric ulceration, renal impairment or cardiovascular events. The most common side effects are mild GI upset and nausea. Because it may have mild anticoagulant properties at very high doses, caution is warranted with warfarin. It may theoretically reduce the efficacy of immunosuppressive drugs by modulating immune function.

India-Specific Context

  • Sanskrit/Hindi name: Shallaki (शल्लकी), Sallaki, Kunduru
  • Ayurvedic classical texts: Shallaki is extensively documented in Charaka Samhita, Sushruta Samhita and Ashtanga Hridaya as a Shothahara (anti-inflammatory) and Vatahara (Vata-pacifying) herb. It is specifically indicated for Sandhigata Vata (osteoarthritis/joint disorders) and Vatavyadhi (neuromuscular disorders). It is a key ingredient in Yograj Guggulu and Mahayograj Guggulu.
  • Indian brands: Widely available on Amazon.in from Teamex, HealthyHey Nutrition, STAY ALIVE, Generic brands and Baidyanath at ₹400–1,500 for 30–120 capsules. Look for products specifying AKBA content or total boswellic acid percentage.
  • Regulatory status: Not a Schedule H drug; sold as a dietary supplement and Ayurvedic proprietary medicine. The AYUSH Ministry recognises Boswellia as a traditional medicine.
  • Cultivation: Boswellia serrata is native to the dry deciduous forests of Madhya Pradesh, Rajasthan, Gujarat and Andhra Pradesh. Indian Shallaki is considered pharmacologically equivalent to African frankincense (Boswellia carterii).

Traditional Use in Indian Medicine

Shallaki holds a prestigious place in Ayurvedic Vata management. Charaka Samhita (Chikitsa Sthana 28) describes it for Sandhigata Vata — the classical Ayurvedic equivalent of osteoarthritis. The resin is Tikshna (penetrating), Laghu (light) and Snigdha (unctuous), with a bitter taste and warming post-digestive effect. Traditional practitioners apply Shallaki resin paste locally on swollen joints and prescribe it internally with ghee for Vata disorders. The modern isolation and standardisation of AKBA validates this empirical use, providing a molecular explanation for Shallaki’s efficacy in joint inflammation — 5-LOX inhibition reduces leukotriene-mediated synovial inflammation and cartilage degradation.

Added to your stack.